Nephrogen
New York
About Nephrogen
Nephrogen is a biotech company in New York City developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $20.0K
- Funding stage: Seed
- Last round: Pre-Seed (Aug 2025)
- Website: nephrogenbiotech.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nephrogen-108838 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.